SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Sonoma Pharmaceuticals, Inc.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.12+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $4.31M
- P/E (TTM)
- –
- Dividend yield
- –
Sonoma Pharmaceuticals, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shipping and Handling [Member] | $180.00K | $18.00K | $28.00K | $42.00K | $52.00K | $37.00K | $57.00K | $55.00K | $46.00K | $49.00K | 0.9% | +900.0% |
| Service [Member] | – | – | – | $1.35M | $449.00K | $112.00K | $151.00K | $1.09M | $995.00K | $868.00K | – | – |
| Product [Member] | – | $13.73M | $12.31M | $11.93M | $12.18M | $18.52M | $17.78M | $17.88M | $15.66M | $11.96M | – | – |
| Human Care [Member] | – | – | – | – | – | – | – | $15.91M | $14.28M | – | – | – |
| Animal Skin Care [Member] | – | – | – | – | – | – | – | $1.97M | $1.39M | – | – | – |
By region
From the segment and revenue-disaggregation notes of Sonoma Pharmaceuticals's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.